Observational Study of Patients Using NovoRapid® or Soluble Human Insulin for Treatment of Type 2 Diabetes
Status:
Completed
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Europe. The aim of this observational study is to evaluate the
incidence of major hypoglycaemic episodes in patients with type 2 diabetes treated with
NovoRapid® or Soluble Human Insulin under normal clinical practice conditions.